These outcomes, along with a prior report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the concept of targeting ACKR3 as a singular strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-associated disorders. Disclaimer: The above is a https://nielsx703dzv2.cosmicwiki.com/user